BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38534921)

  • 21. MCP-1 and MIP-3α Secreted from Necrotic Cell-Treated Glioblastoma Cells Promote Migration/Infiltration of Microglia.
    Jung Y; Ahn SH; Park H; Park SH; Choi K; Choi C; Kang JL; Choi YH
    Cell Physiol Biochem; 2018; 48(3):1332-1346. PubMed ID: 30048972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglia in Cancer: For Good or for Bad?
    da Fonseca AC; Amaral R; Garcia C; Geraldo LH; Matias D; Lima FR
    Adv Exp Med Biol; 2016; 949():245-261. PubMed ID: 27714693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glioblastoma hijacks microglial gene expression to support tumor growth.
    Maas SLN; Abels ER; Van De Haar LL; Zhang X; Morsett L; Sil S; Guedes J; Sen P; Prabhakar S; Hickman SE; Lai CP; Ting DT; Breakefield XO; Broekman MLD; El Khoury J
    J Neuroinflammation; 2020 Apr; 17(1):120. PubMed ID: 32299465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
    Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
    J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EZH2 suppression in glioblastoma shifts microglia toward M1 phenotype in tumor microenvironment.
    Yin Y; Qiu S; Li X; Huang B; Xu Y; Peng Y
    J Neuroinflammation; 2017 Nov; 14(1):220. PubMed ID: 29132376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies.
    Morisse MC; Jouannet S; Dominguez-Villar M; Sanson M; Idbaih A
    Expert Rev Neurother; 2018 Sep; 18(9):729-737. PubMed ID: 30099909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.
    Szulzewsky F; Pelz A; Feng X; Synowitz M; Markovic D; Langmann T; Holtman IR; Wang X; Eggen BJ; Boddeke HW; Hambardzumyan D; Wolf SA; Kettenmann H
    PLoS One; 2015; 10(2):e0116644. PubMed ID: 25658639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatially resolved transcriptomic profiles reveal unique defining molecular features of infiltrative 5ALA-metabolizing cells associated with glioblastoma recurrence.
    Andrieux G; Das T; Griffin M; Straehle J; Paine SML; Beck J; Boerries M; Heiland DH; Smith SJ; Rahman R; Chakraborty S
    Genome Med; 2023 Jul; 15(1):48. PubMed ID: 37434262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.
    Wu H; Guo C; Wang C; Xu J; Zheng S; Duan J; Li Y; Bai H; Xu Q; Ning F; Wang F; Yang Q
    Cancer Sci; 2023 Jun; 114(6):2609-2621. PubMed ID: 36853018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-Cell Transcriptome Profiling Signatures and Alterations of Microglia Associated With Glioblastoma Associate Microglia Contribution to Tumor Formation.
    Xia H; Deng L; Meng S; Liu X; Zheng C
    Pathol Oncol Res; 2022; 28():1610067. PubMed ID: 35693633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
    Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
    Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
    [No Abstract]   [Full Text] [Related]  

  • 32. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
    Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
    Front Immunol; 2020; 11():835. PubMed ID: 32457755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
    Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
    OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamic trajectory and cell communication of different cell clusters in malignant progression of glioblastoma].
    Cai X; Wang R; Wang S; Ren Z; Yu Q; Li D
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Apr; 56(2):199-206. PubMed ID: 38595234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma.
    Pires-Afonso Y; Niclou SP; Michelucci A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of key genes involved in the recurrence of glioblastoma multiforme using weighted gene co-expression network analysis and differential expression analysis.
    Ren P; Wang J; Li L; Lin X; Wu G; Chen J; Zeng Z; Zhang H
    Bioengineered; 2021 Dec; 12(1):3188-3200. PubMed ID: 34238116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
    Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
    J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
    Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
    Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage/microglial cell subpopulations in glioblastoma multiforme relapses are differentially altered by radiochemotherapy.
    Deininger MH; Pater S; Strik H; Meyermann R
    J Neurooncol; 2001 Dec; 55(3):141-7. PubMed ID: 11859968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.